(Q33364647)

26 July 2017

title

Antiphospholipid antibodies in immune thrombocytopenic purpura tend to emerge in exacerbation and decline in remission (English)

1 reference

Immune thrombocytopenic purpura

26 July 2017

1 reference

1 reference

1 reference

Carlos J Bidot

1

1 reference

26 July 2017

Wenche Jy

2

1 reference

26 July 2017

Lawrence L Horstman

3

1 reference

26 July 2017

Eugene R Ahn

4

1 reference

26 July 2017

Joaquin J Jimenez

5

1 reference

26 July 2017

Miriam Yaniz

6

1 reference

26 July 2017

Gabriela Lander

7

1 reference

26 July 2017

Yeon S Ahn

8

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

British Journal of Haematology

26 July 2017

published in

1 reference

26 July 2017

volume

128

1 reference

26 July 2017

issue

3

1 reference

26 July 2017

page(s)

366-372

1 reference

Current status and implications of autoimmune antiphospholipid antibodies in relation to thrombotic disease

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05314.X

Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05314.X

Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05314.X

Anti-prothrombin antibodies: assay conditions and clinical associations in the anti-phospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05314.X

Platelet-mediated modulation of adaptive immunity. A communication link between innate and adaptive immune compartments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05314.X

Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05314.X

Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05314.X

Specific antiplatelet glycoprotein autoantibodies are associated with the thrombocytopenia of primary antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05314.X

Immunologic mechanisms in idiopathic and neonatal thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05314.X

The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05314.X

Antiphospholipid antibodies: basic immunology and assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05314.X

Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05314.X

International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05314.X

10.1111/J.1365-2141.2004.05314.X

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference